The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering

Rosamond, 2007, Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 115, e69, 10.1161/CIRCULATIONAHA.106.179918 Human, 2001, Characterization of the immune response to valve bioprostheses and its role in primary tissue failure, Ann Thorac Surg, 71, S385, 10.1016/S0003-4975(01)02492-4 Manji, 2006, Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection, Circulation, 114, 318, 10.1161/CIRCULATIONAHA.105.549311 Shinoka, 1995, Tissue engineering heart valves: valve leaflet replacement study in a lamb model, Ann Thorac Surg, 60, S513, 10.1016/S0003-4975(21)01185-1 Sacks, 2009, Bioengineering challenges for heart valve tissue engineering, Annu Rev Biomed Eng, 11, 289, 10.1146/annurev-bioeng-061008-124903 Mendelson, 2006, Heart valve tissue engineering: concepts, approaches, progress, and challenges, Ann Biomed Eng, 34, 1799, 10.1007/s10439-006-9163-z Schmidt, 2000, Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering, Biomaterials, 21, 2215, 10.1016/S0142-9612(00)00148-4 Yang, 2009, Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves, J Biomed Mater Res B Appl Biomater, 91B, 354, 10.1002/jbm.b.31409 Mirsadraee, 2006, Development and characterization of an acellular human pericardial matrix for tissue engineering, Tissue Eng, 12, 763, 10.1089/ten.2006.12.763 Goncalves, 2005, Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens, J Heart Valve Dis, 14, 212 Simon, 2003, Early failure of the tissue engineered porcine heart valve SYNERGRAFT(TM) in pediatric patients, Eur J Cardiothorac Surg, 23, 1002, 10.1016/S1010-7940(03)00094-0 Rieder, 2005, Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells, Circulation, 111, 2792, 10.1161/CIRCULATIONAHA.104.473629 Kasimir, 2006, Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves, J Heart Valve Dis, 15, 278 Wilhelmi, 2003, Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep, Int J Artif Organs, 26, 411, 10.1177/039139880302600507 Bastian, 2008, IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue, Biomaterials, 29, 1824, 10.1016/j.biomaterials.2008.01.005 Kasimir, 2005, Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves, Tissue Eng, 11, 1274, 10.1089/ten.2005.11.1274 Shaw, 2003, Sample preparation for two-dimensional gel electrophoresis, Proteomics, 3, 1408, 10.1002/pmic.200300471 Herbert, 1998, Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent, Electrophoresis, 19, 845, 10.1002/elps.1150190540 Weiss, 2008, Protein solubilization, 135 Rabilloud, 2002, Protein solubility in two-dimensional electrophoresis, 131 Koolman, 2005 Upreti, 1991, Preparation of representative homogenates of biological tissues: effect of salt on protein extraction, Anal Biochem, 198, 298, 10.1016/0003-2697(91)90428-V Griffiths, 2008, Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue, Electrophoresis, 29, 4508, 10.1002/elps.200800108 Griffiths, 2008, Immunoproteomic identification of bovine pericardium xenoantigens, Biomaterials, 29, 3514, 10.1016/j.biomaterials.2008.05.006 1996 Sanchez, 2007, Fixation of vascular grafts with increased glutaraldehyde concentration enhances mechanical properties without increasing calcification, ASAIO J, 53, 257, 10.1097/MAT.0b013e318033a68f Ling, 1996, Uniaxial true stress-strain after necking, AMP J Tech, 5, 37 Woessner, 1961, The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid, Arch Biochem Biophys, 93, 440, 10.1016/0003-9861(61)90291-0 Gilbert, 2006, Decellularization of tissues and organs, Biomaterials, 27, 3675 Masutani, 2005, The thioredoxin system in retroviral infection and apoptosis, Cell Death Differ, 12, 991, 10.1038/sj.cdd.4401625 De Bernardez Clark, 1998, Refolding of recombinant proteins, Curr Opin Biotechnol, 9, 157, 10.1016/S0958-1669(98)80109-2 Roussel, 1998, Alterations in acid-base balance and serum electrolyte concentrations in cattle: 632 cases (1984–1994), J Am Vet Med Assoc, 212, 1769 Merryman, 2006, Defining biomechanical endpoints for tissue engineered heart valve leaflets from native leaflet properties, Prog Ped Card, 21, 153, 10.1016/j.ppedcard.2005.11.001 Thubrikar, 1990 Vesely, 1997, The role of elastin in aortic valve mechanics, J Biomech, 31, 115, 10.1016/S0021-9290(97)00122-X Stradins, 2004, Comparison of biomechanical and structural properties between human aortic and pulmonary valve, Eur J Cardiothorac Surg, 26, 634, 10.1016/j.ejcts.2004.05.043 O’Brien, 1999, The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation, Semin Thorac Cardiovasc Surg, 11, 194 Kasimir, 2003, Comparison of different decellularization procedures of procine heart valves, Int J Artif Organs, 26, 421, 10.1177/039139880302600508 Schenke-Layland, 2003, Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves, J Struct Biol, 143, 201, 10.1016/j.jsb.2003.08.002 Stavnezer, 2008, Mechanism and regulation of class switch recombination, Annu Rev Immunol, 26, 261, 10.1146/annurev.immunol.26.021607.090248 Meyer, 2006, Comparison of aortic valve allograft decellularization techniques in the rat, J Biomed Mater Res A, 79A, 254, 10.1002/jbm.a.30777